3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid

C21H20BrNO7S — CID 160614159

IUPAC3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid
SMILESCc1cccc(S(=O)(=O)N2C[C@H](C3CC(C(=O)O)(C(=O)O)C3)Oc3ccc(Br)cc32)c1
InChIInChI=1S/C21H20BrNO7S/c1-12-3-2-4-15(7-12)31(28,29)23-11-18(30-17-6-5-14(22)8-16(17)23)13-9-21(10-13,19(24)25)20(26)27/h2-8,13,18H,9-11H2,1H3,(H,24,25)(H,26,27)/t18-/m1/s1
InChIKeyRFWGPITYZASUAO-GOSISDBHSA-N
MW510.36 g/mol
LogP3.28
Rot. Bonds5

About 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid

3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid (PubChem CID 160614159) has the molecular formula C21H20BrNO7S and a molecular weight of 510.36 g/mol. Its IUPAC name is 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid.

Molecular Properties

Compound Name3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid
PubChem CID160614159
Molecular FormulaC21H20BrNO7S
Molecular Weight510.36 g/mol
Exact Mass509.01
IUPAC Name3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid
SMILESCc1cccc(S(=O)(=O)N2C[C@H](C3CC(C(=O)O)(C(=O)O)C3)Oc3ccc(Br)cc32)c1
InChIInChI=1S/C21H20BrNO7S/c1-12-3-2-4-15(7-12)31(28,29)23-11-18(30-17-6-5-14(22)8-16(17)23)13-9-21(10-13,19(24)25)20(26)27/h2-8,13,18H,9-11H2,1H3,(H,24,25)(H,26,27)/t18-/m1/s1
InChIKeyRFWGPITYZASUAO-GOSISDBHSA-N
XLogP3.28
TPSA121.21 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500510.36
LogP ≤ 53.28
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid?
The IUPAC name of 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid (CID 160614159) is 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid.
What is the SMILES notation for 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid?
The canonical SMILES for 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid is Cc1cccc(S(=O)(=O)N2C[C@H](C3CC(C(=O)O)(C(=O)O)C3)Oc3ccc(Br)cc32)c1.
What is the InChIKey of 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid?
The InChIKey is RFWGPITYZASUAO-GOSISDBHSA-N. The full InChI is InChI=1S/C21H20BrNO7S/c1-12-3-2-4-15(7-12)31(28,29)23-11-18(30-17-6-5-14(22)8-16(17)23)13-9-21(10-13,19(24)25)20(26)27/h2-8,13,18H,9-11H2,1H3,(H,24,25)(H,26,27)/t18-/m1/s1.
What are the key properties of 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid?
3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid has a molecular weight of 510.36 g/mol, XLogP of 3.28, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(2S)-6-bromo-4-(3-methylphenyl)sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]cyclobutane-1,1-dicarboxylic acid is sourced from PubChem (CID 160614159), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).